Drug

2%menthol

73 flagged reaction(s) · 1,090 total co-reports · max PRR 80.1

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Hypercholesterolaemia	36	80.1	83.1	signal
2	Joint Dislocation	23	46.4	47.5	signal
3	Dizziness Postural	20	44.2	45.1	signal
4	Helicobacter Infection	21	43.8	44.7	signal
5	Secretion Discharge	25	43.0	44.1	signal
6	Scratch	20	41.0	41.9	signal
7	Autoimmune Disorder	15	33.3	33.8	signal
8	Hip Arthroplasty	22	30.8	31.4	signal
9	Irritable Bowel Syndrome	29	28.8	29.7	signal
10	Joint Range Of Motion Decreased	18	28.6	29.1	signal
11	Erythema Multiforme	12	27.3	27.6	signal
12	Sciatica	18	24.1	24.5	signal
13	Folliculitis	11	22.6	22.8	signal
14	Prescribed Overdose	19	20.8	21.2	signal
15	Fibromyalgia	23	20.1	20.5	signal
16	Pemphigus	11	18.8	19.0	signal
17	Joint Stiffness	23	18.6	19.0	signal
18	C-reactive Protein Increased	31	18.1	18.6	signal
19	Lip Swelling	28	17.9	18.4	signal
20	Hand Deformity	11	17.8	18.0	signal
21	Bronchospasm	12	17.8	18.0	signal
22	Impaired Healing	27	17.4	17.9	signal
23	End Stage Renal Disease	15	17.3	17.5	signal
24	Blood Calcium Decreased	9	16.9	17.1	signal
25	Synovitis	14	16.5	16.7	signal
26	Hallucination, Visual	16	16.2	16.4	signal
27	Laryngitis	8	15.6	15.8	signal
28	Pulmonary Fibrosis	14	15.5	15.7	signal
29	Pericarditis	12	15.3	15.5	signal
30	Knee Arthroplasty	14	14.2	14.4	signal
31	Liver Injury	16	14.0	14.3	signal
32	Type 2 Diabetes Mellitus	22	13.8	14.1	signal
33	Red Blood Cell Sedimentation Rate Increased	7	13.4	13.5	signal
34	Foot Deformity	7	13.4	13.5	signal
35	Blood Cholesterol Increased	29	13.2	13.6	signal
36	Infusion Related Reaction	41	13.2	13.7	signal
37	Osteoarthritis	26	13.0	13.3	signal
38	Coeliac Disease	6	13.0	13.0	signal
39	Prescribed Underdose	12	12.8	12.9	signal
40	Tubulointerstitial Nephritis	11	12.5	12.6	signal
41	Haematoma	15	12.2	12.4	signal
42	Lower Limb Fracture	11	12.2	12.3	signal
43	Therapeutic Product Effect Decreased	25	11.9	12.2	signal
44	Hypothermia	5	10.5	10.5	signal
45	Glossodynia	11	10.4	10.5	signal
46	Wound	13	9.9	10.0	signal
47	Contraindicated Product Administered	14	9.8	10.0	signal
48	Lower Respiratory Tract Infection	21	9.8	10.0	signal
49	Personality Change	4	9.1	9.1	signal
50	Nasal Congestion	25	9.1	9.3	signal
51	Nephropathy	4	9.0	9.1	signal
52	Photosensitivity Reaction	7	9.0	9.1	signal
53	Pharyngeal Swelling	4	8.9	8.9	signal
54	Blood Pressure Systolic Increased	8	8.7	8.7	signal
55	Immunodeficiency	6	8.6	8.7	signal
56	Diabetes Mellitus Inadequate Control	7	8.4	8.4	signal
57	Drug Administration Error	12	8.2	8.3	signal
58	Injury	27	8.1	8.3	signal
59	Nervousness	20	8.1	8.2	signal
60	Localised Infection	9	7.9	8.0	signal
61	Systemic Lupus Erythematosus	13	7.8	7.9	signal
62	Sedation	9	7.3	7.4	signal
63	Psoriatic Arthropathy	13	6.9	6.9	signal
64	Application Site Pain	7	6.7	6.8	signal
65	Cytokine Release Syndrome	6	6.7	6.7	signal
66	Serotonin Syndrome	6	6.7	6.7	signal
67	Pregnancy	6	6.3	6.3	signal
68	Femur Fracture	8	5.5	5.5	signal
69	Complication Associated With Device	3	4.8	4.8	signal
70	Uveitis	3	4.7	4.7	signal
71	Injection Site Reaction	15	4.6	4.7	signal
72	Injection Site Bruising	16	4.3	4.4	signal
73	Application Site Erythema	3	2.4	2.4	no signal